Owner | Filings | Transaction Date | Type of Owner |
---|---|---|---|
Shi Yongchun | 0001822285 | Dec-02-2019 | director |
Liu Xiefeng | 0001822288 | Dec-02-2019 | director |
Tian Guoshuang | 0001822296 | Dec-02-2019 | director |
Wu Xuehai | 0001822275 | Oct-06-2015 | director |
Han Xingming | 0001548241 | Dec-13-2012 | director |
WASSERMAN ADAM C | 0001171265 | Jul-09-2012 | officer: Chief Financial Officer |
Qi Guifang | 0001548242 | Jul-09-2012 | director, officer: Treasurer |
Wang Zhiguo | 0001548243 | Jul-09-2012 | director, officer: President and Secretary |
Coming soon!
Coming soon!
Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Yew Bio-Pharm Group, Inc.
Filings | Format | Description | Filed/Effective | File/Film Number |
---|---|---|---|---|
8-K | Document | Current report filing Acc-no: 0001493152-22-007955 (34 Act) Size: 201 KB |
Mar-29-2022 | 22777511 |
DEFA14C | Document | Definitive additional information statement materials including Rule 14(a)(12) material Acc-no: 0001493152-21-030003 (34 Act) Size: 37 KB |
Nov-29-2021 | 211456133 |
DEF 14C | Document | Definitive information statements Acc-no: 0001493152-21-030000 (34 Act) Size: 301 KB |
Nov-29-2021 | 211456112 |
PRE 14C | Document | Preliminary information statement not related to a contested matter or merger/acquisition Acc-no: 0001493152-21-028625 (34 Act) Size: 301 KB |
Nov-15-2021 | 211411006 |
10-Q | Document | Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001493152-21-028337 (34 Act) Size: 5134 KB |
Nov-15-2021 | 211406432 |
10-Q | Document | Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001493152-21-020137 (34 Act) Size: 4998 KB |
Aug-16-2021 | 211177791 |
8-K | Document | Current report filing Acc-no: 0001493152-21-017857 (34 Act) Size: 29 KB |
Jul-27-2021 | 211117956 |
10-Q | Document | Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001493152-21-011687 (34 Act) Size: 3660 KB |
May-17-2021 | 21927760 |
10-K | Document | Annual report pursuant to section 13 and 15(d) Acc-no: 0001493152-21-007242 (34 Act) Size: 6896 KB |
Mar-30-2021 | 21788398 |
8-K | Document | Current report filing Acc-no: 0001493152-21-000204 (34 Act) Size: 28 KB |
Jan-05-2021 | 21505336 |
10-Q | Document | Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001493152-20-021299 (34 Act) Size: 4460 KB |
Nov-13-2020 | 201311339 |
DEFA14C | Document | Definitive additional information statement materials including Rule 14(a)(12) material Acc-no: 0001213900-20-030992 (34 Act) Size: 30 KB |
Oct-13-2020 | 201234849 |
DEF 14C | Document | Definitive information statements Acc-no: 0001213900-20-030989 (34 Act) Size: 304 KB |
Oct-13-2020 | 201234843 |
3 | Document | Initial statement of beneficial ownership of securities Acc-no: 0001822275-20-000001 ( Act) Size: 3 KB |
Sep-29-2020 | |
3 | Document | Initial statement of beneficial ownership of securities Acc-no: 0001822285-20-000001 ( Act) Size: 3 KB |
Sep-29-2020 | |
3 | Document | Initial statement of beneficial ownership of securities Acc-no: 0001822288-20-000001 ( Act) Size: 3 KB |
Sep-29-2020 | |
3 | Document | Initial statement of beneficial ownership of securities Acc-no: 0001822296-20-000001 ( Act) Size: 3 KB |
Sep-29-2020 | |
PRE 14C | Document | Preliminary information statement not related to a contested matter or merger/acquisition Acc-no: 0001213900-20-028668 (34 Act) Size: 226 KB |
Sep-28-2020 | 201204457 |
8-K | Document | Current report filing Acc-no: 0001213900-20-026609 (34 Act) Size: 19 KB |
Sep-15-2020 | 201175369 |
10-Q | Document | Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001213900-20-022258 (34 Act) Size: 4656 KB |
Aug-14-2020 | 201105178 |
Recent 20 filings. View all Yew Bio-Pharm Group, Inc. filings
Very good communication and delivery made within the timeframe I was advised of
It's being easier working on the website. And I recommend, it's a great website
Thanks I look forward to using the product to improve my skin tone
Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.
© 2022 CompaniesBIO.Com. All rights reserved. Operated by